Diagnostic Values of Serum Levels of Pepsinogens and Gastrin-17 for Screening Gastritis and Gastric Cancer in a High Risk Area in Northern Iran

Nejadi-Kelarijani, Fatemeh; Roshandel, Gholamreza; Semnani, Shahryar; Ahmadi, Ali; Faghani, Behzad; Besharat, Sima; Akhavan-Tabib, Atefeh; Amiriani, Taghi

추천

검색

자료유형: 학술저널

저자정보: Nejadi-Kelarijani, Fatemeh (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Roshandel, Gholamreza (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Semnani, Shahryar (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Ahmadi, Ali (Department of Pathology, Tehran University of Medical Sciences) Faghani, Behzad (Department of Pathology, Tehran University of Medical Sciences) Besharat, Sima (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Akhavan-Tabib, Atefeh (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences) Amiriani, Taghi (Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제15권 제17호

발행연도: 2014.1

수록면: 7,433 - 7,436 (4page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Gastric cancer (GC) is the second cause of cancer related death in the world. It may develop by progression from its precancerous condition, called gastric atrophy (GA) due to gastritis. The aim of this study was to evaluate the accuracy of serum levels of pepsinogens (Pg) and gastrin-17 (G17) as non-invasive methods to discriminate GA or GC (GA/GC) patients. Materials and Methods: Subjects referred to gastrointestinal clinics of Golestan province of Iran during 2010 and 2011 were invited to participate. Serum levels of PgI, PgII and G17 were measured using a GastroPanel kit. Based on the pathological examination of endoscopic biopsy samples, subjects were classified into four groups: normal, non-atrophic gastritis, GA, and GC. Receiver operating curve (ROC) analysis was used to determine cut-off values. Indices of validity were calculated for serum markers. Results: Study groups were normal individuals (n=74), non-atrophic gastritis (n=90), GA (n=31) and GC patients (n=30). The best cut-off points for PgI, PgI/II ratio, G17 and HP were $80{\mu}g/L$, 10, 6 pmol/L, and 20 EIU, respectively. PgI could differentiate GA/GC with high accuracy (AUC=0.83; 95%CI: 0.76-0.89). The accuracy of a combination of PgI and PgI/II ratio for detecting GA/GC was also relatively high (AUC=0.78; 95%CI: 0.70-0.86). Conclusions: Our findings suggested PgI alone as well as a combination of PgI and PgI/II ratio are valid markers to differentiate GA/GC. Therefore, Pgs may be considered in conducting GC screening programs in high-risk areas.

#Gastric cancer #pepsinogen #gastrin 17 #early detection #screening programs

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

이 논문의 저자 정보

Nejadi-Kelarijani, Fatemeh

소속기관 Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences